Prevenirea cancerului prin intermediul unor programe de screening

Breast cancer genetic or not,

Subscribe What is EndoPredict?

polyomaviridae papillomaviridae laryngeal papillomatosis adults

EndoPredict is a 2nd generation multi-gene breast cancer recurrence test for pre- or postmenopausal women newly diagnosed with early-stage breast cancer. Created for the purpose of highly accurate assessment of 5 to year risk of distant recurrence of the disease EndoPredict combines into an unique indicator EPClin score gene expression with clinically pathological features providing outstanding prognostic performance that will ensure the healthcare professional that chemotherapy is or is not required to accompany endocrine treatment.

breast cancer genetic or not

Considering these aspects, realizing that the cancer has a high or low risk of recurrence can help patients and doctors decide if chemotherapy after surgery is or is not necessary to accompany endocrine therapy. What DNA sample is required to perform the test?

  1. Hpv virus epstein barr
  2. Extended BRCA Test – AMS GENETIC LAB

EndoPredict requires a simple tumor tissue sample that is customarily prepared for the pathology exam upon surgical tumor removal. The latest diagnostic and prognostic technology allows healthcare breast cancer genetic or not to determine suitable treatment procedures based completely on the needs and DNA of the patient.

  • Если не преследовать Хейла, «черный ход» останется секретом.

  • Papillomavirus humain frequence
  • С помощью «ТРАНСТЕКСТА», взломавшего шифр, ему удалось узнать о заговоре и бомбе, подложенной в школе иврита в Лос-Анджелесе.

Therefore, the decision of breast cancer therapy increasingly depends on your own mix of gene markers. In this context, EndoPredict reveals critical information about the way that a tumor is likely to react at a genetic level.

Accepted Apr Copyright © The Authors.

Why is EndoPredict relevant? At the same time it can convince those at low risk of recurrence that chemotherapy is not mandatory.

BRCA The Breast Cancer Gene

Thus, the test is practically an important step ahead towards the goal of truly customized care, helping breast cancer therapists to pancreatic cancer famous both over- and under treatment of breast cancer with chemotherapy. When do breast cancer metastases occur?

Breast cancer metastases mostly happen within the first three years following the initial diagnosis. One of the objectives of EndoPredict test breast cancer genetic or not to calculate the tendency for cancer recurrence or late metastases. What is the best treatment to lower the risk of developing a recurrence of the breast cancer?

breast cancer genetic or not

For early and locally advanced breast cancer the first clinical step is, of course, to surgically remove the tumor. The next step requires a more complex decision.

Around half of the intermediate patients currently receive unnecessary chemotherapy, which is very stressful for the organism, has serious side-effects, is toxic by nature and has a significant impact on mortality.

Prevenirea cancerului prin intermediul unor programe de screening

For that reason, it is very important to be able to identify the patients who would not adequately benefit from chemotherapy in any case and to be able to provide a more focused care, including systemic endocrine therapy, instead. EndoPredict  manages to make this happen. The result? The ones who would not adequately benefit from chemotherapy can be spared from this treatment and its correlated side-effects.

1. Introduction

How does the test work? Performed on preserved breast tumor tissue that was removed during the initial biopsy or surgery, the EndoPredict test analyzes the activity of rigorously selected prolipherative and breast cancer genetic or not genes in breast cancer cells.

breast cancer genetic or not cura papilloma virus utero

These genes are linked to the possibility that the cancer will come back in a different part of the body within 15 years after initial diagnosis. The test includes the size of the breast tumor and whether or not the cancer is in the lymph nodes when calculating the risk score. The scores are recognized either low-risk or high-risk: an EPclin Risk Score higher than 3.

The benefits are certain in some cases: life years gained for those with curable disease, avoidance of morbidity, reassurance that the disease is at a very early stage, avoiding expenses of treatment for advanced cancers and extra years of productivity. But screening tests also have disadvantages, so a balanced decision must be made, with the help of clinical randomized trials. In this article I will present the current methods for screening accepted for general population and particular screening reserved for persons at high risk. Breast cancer genetic or not in the first case the benefit is proven, the use of these methods in practice varies largely due to lack of resources and well designed health programs.

With the help of our partner physicians, experts in genetic counseling in breast cancer, you will find out the benefits of the EndoPredict test, understand the clinical results and make the right decisions for your future health. Fill this form to get in touch with a doctor for a clinic consultation and testing.

hpv virus en pap 1